Biotest AG: Biotest accelerates trimodulin development in hospitalized COVID-19 patients with federa

DGAP-News: Biotest AG / Key word(s): Research Update23.11.2021 / 15:34 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest accelerates trimodulin development in hospitalized COVID-19 patients with federal funding in the volume of 29 million EUR- The German Federal Ministry of E...

Related Keywords

Germany ,Hanover ,Niedersachsen ,Dreieich ,Hessen ,Munich ,Bayern ,Berlin ,Frankfurt ,Brandenburg ,German ,Dirk Neum ,Monika Buttkereit ,Georg Flo ,German Ministries Of Health ,German Federal Ministry Of Health ,German Federal Ministry Of Education ,German Regulatory Authority ,Distribution Services ,Education Research ,Research Update ,German Federal Ministry ,German Ministries ,German Government ,Chief Operations Officer ,Clinical Strategy ,Biotest Corporate Clinical Research ,Igm Concentrate ,Prime Standard ,Corporate News ,Regulatory Announcements ,